Chimerix enrolls dying 7-year-old in pilot study, skirts ethical quandary
After enduring a social media firestorm this week vilifying the firm for not providing its antiviral candidate brincidofovir to a dying 7-year-old boy on a compassionate use basis, Chimerix Inc. found a way to get the drug to Josh Hardy without setting a potentially dangerous ethical precedent.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter